作者: Mario Menschikowski , Gabriele Siegert , Albert Hagelgans
DOI:
关键词:
摘要: The invention relates to a method and means for diagnosing tumors, in particular an early diagnosis (prevention) differentiating between benign malignant tumors using PCR, bodily fluids. according the is characterized by combination of pre-amplification process wherein methylated DNA sequences are amplified more strongly than non-methylated sequences, subsequent quantification special digital which significantly used normally prior art. As comparison data indicates, advantageously allows clear reliable conclusion as whether tumor disease present or not. suitable screening (prevention), monitoring progress disease, order exclude minimal residual (MRD), differential carcinoma tumors.